HomeScienceDifferential persistence of neutralizing antibody against SARS-CoV-2 in post immunized Bangladeshi population

Differential persistence of neutralizing antibody against SARS-CoV-2 in post immunized Bangladeshi population

[ad_1]

  • Jakhmola, S., Indari, O., Chatterjee, S. & Jha, H. C. SARS-CoV-2, an underestimated pathogen of the nervous system. SN Compr. Clin. Med. https://doi.org/10.1007/s42399-020-00522-7 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cucinotta, D. & Vanelli, M. WHO declares COVID-19 a pandemic. Acta Biomed. 91, 157–160. https://doi.org/10.23750/abm.v91i1.9397 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mallah, S. I. et al. COVID-19: Breaking down a global health crisis. Ann. Clin. Microbiol. Antimicrob. 20, 35. https://doi.org/10.1186/s12941-021-00438-7 (2021).

    MathSciNet 
    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Duan, K. et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc. Natl. Acad. Sci. USA 117, 9490–9496. https://doi.org/10.1073/pnas.2004168117 (2020).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shen, C. et al. Treatment of 5 critically Ill patients with COVID-19 with convalescent plasma. JAMA 323, 1582–1589. https://doi.org/10.1001/jama.2020.4783 (2020).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wu, Y. et al. A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science 368, 1274–1278. https://doi.org/10.1126/science.abc2241 (2020).

    ADS 
    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cao, Y. et al. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients’ B cells. Cell 182, 73-84 e16. https://doi.org/10.1016/j.cell.2020.05.025 (2020).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shi, R. et al. A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature 584, 120–124. https://doi.org/10.1038/s41586-020-2381-y (2020).

    ADS 
    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Suthar, M. S. et al. Rapid generation of neutralizing antibody responses in COVID-19 patients. Cell Rep. Med. 1, 100040. https://doi.org/10.1016/j.xcrm.2020.100040 (2020).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jackson, L. A. et al. An mRNA vaccine against SARS-CoV-2: Preliminary report. N. Engl. J. Med. 383, 1920–1931. https://doi.org/10.1056/NEJMoa2022483 (2020).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Dan, J. M. et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science https://doi.org/10.1126/science.abf4063 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Robbiani, D. F. et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature 584, 437–442. https://doi.org/10.1038/s41586-020-2456-9 (2020).

    ADS 
    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Voysey, M. et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397, 99–111. https://doi.org/10.1016/S0140-6736(20)32661-1 (2021).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wheatley, A. K. et al. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nat. Commun. 12, 1162. https://doi.org/10.1038/s41467-021-21444-5 (2021).

    ADS 
    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wang, P. et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature 593, 130–135. https://doi.org/10.1038/s41586-021-03398-2 (2021).

    ADS 
    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Rogers, T. F. et al. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science 369, 956–963. https://doi.org/10.1126/science.abc7520 (2020).

    ADS 
    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Temperton, N. J. et al. Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. Emerg. Infect. Dis. 11, 411–416. https://doi.org/10.3201/eid1103.040906 (2005).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Choe, P. G. et al. MERS-CoV antibody responses 1 year after symptom Onset, South Korea, 2015. Emerg. Infect. Dis. 23, 1079–1084. https://doi.org/10.3201/eid2307.170310 (2017).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gaebler, C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature 591, 639–644. https://doi.org/10.1038/s41586-021-03207-w (2021).

    ADS 
    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Widge, A. T. et al. Durability of responses after SARS-CoV-2 mRNA-1273 vaccination. N. Engl. J. Med. 384, 80–82. https://doi.org/10.1056/NEJMc2032195 (2021).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Gebhard, C., Regitz-Zagrosek, V., Neuhauser, H. K., Morgan, R. & Klein, S. L. Impact of sex and gender on COVID-19 outcomes in Europe. Biol. Sex Differ. 11, 29. https://doi.org/10.1186/s13293-020-00304-9 (2020).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Meng, Y. et al. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients. PLoS Pathog. 16, e1008520. https://doi.org/10.1371/journal.ppat.1008520 (2020).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Takahashi, T. et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature 588, 315–320. https://doi.org/10.1038/s41586-020-2700-3 (2020).

    ADS 
    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Qiu, F. et al. Impacts of cigarette smoking on immune responsiveness: Up and down or upside down? Oncotarget 8, 268–284. https://doi.org/10.18632/oncotarget.13613 (2017).

    Article 
    PubMed 

    Google Scholar
     

  • Ni, L. et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity 52, 971-977 e973. https://doi.org/10.1016/j.immuni.2020.04.023 (2020).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ou, Y., West, J. J., Smith, S. J., Nolte, C. G. & Loughlin, D. H. Air pollution control strategies directly limiting national health damages in the US. Nat. Commun. 11, 957. https://doi.org/10.1038/s41467-020-14783-2 (2020).

    ADS 
    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Abdel-Moneim, A. S., Abdelwhab, E. M. & Memish, Z. A. Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines. Virology 558, 1–12. https://doi.org/10.1016/j.virol.2021.02.007 (2021).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Harvey, W. T. et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. 19, 409–424. https://doi.org/10.1038/s41579-021-00573-0 (2021).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gong, S. Y. et al. Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity. Virology 563, 134–145. https://doi.org/10.1016/j.virol.2021.09.001 (2021).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Chen, R. E. et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat. Med. 27, 717–726. https://doi.org/10.1038/s41591-021-01294-w (2021).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Davies, N. G. et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science https://doi.org/10.1126/science.abg3055 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • van Dorp, L. et al. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2. Nat. Commun. 11, 5986. https://doi.org/10.1038/s41467-020-19818-2 (2020).

    ADS 
    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ramanathan, M., Ferguson, I. D., Miao, W. & Khavari, P. A. SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. Lancet Infect. Dis. 21, 1070. https://doi.org/10.1016/S1473-3099(21)00262-0 (2021).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bruxvoort, K. J. et al. Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: Test negative case-control study. BMJ 375, e068848. https://doi.org/10.1136/bmj-2021-068848 (2021).

    Article 
    PubMed 

    Google Scholar
     

  • Cele, S. et al. Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. Nature 593, 142–146. https://doi.org/10.1038/s41586-021-03471-w (2021).

    ADS 
    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • McKeigue, P. M. et al. Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): A case-control study. Lancet Respir. Med. 10, 566–572. https://doi.org/10.1016/S2213-2600(22)00045-5 (2022).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Reis, B. Y. et al. Effectiveness of BNT162b2 vaccine against delta variant in adolescents. N. Engl. J. Med. 385, 2101–2103. https://doi.org/10.1056/NEJMc2114290 (2021).

    Article 
    PubMed 

    Google Scholar
     

  • Ghosh, S. et al. COVISHIELD (AZD1222) VaccINe effectiveness among healthcare and frontline Workers of INdian Armed Forces: Interim results of VIN-WIN cohort study. Med. J. Armed Forces India 77, S264–S270. https://doi.org/10.1016/j.mjafi.2021.06.032 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sheikh, A. et al. SARS-CoV-2 Delta VOC in Scotland: Demographics, risk of hospital admission, and vaccine effectiveness. Lancet 397, 2461–2462. https://doi.org/10.1016/S0140-6736(21)01358-1 (2021).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Fiolet, T., Kherabi, Y., MacDonald, C. J., Ghosn, J. & Peiffer-Smadja, N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: A narrative review. Clin. Microbiol. Infect. 28, 202–221. https://doi.org/10.1016/j.cmi.2021.10.005 (2022).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Kumar, S., Thambiraja, T. S., Karuppanan, K. & Subramaniam, G. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein. J. Med. Virol. 94, 1641–1649. https://doi.org/10.1002/jmv.27526 (2022).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Hirabara, S. M. et al. SARS-COV-2 variants: Differences and potential of immune evasion. Front. Cell Infect. Microbiol. 11, 781429. https://doi.org/10.3389/fcimb.2021.781429 (2021).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Callaway, E. & Ledford, H. How bad is Omicron? What scientists know so far. Nature 600, 197–199. https://doi.org/10.1038/d41586-021-03614-z (2021).

    ADS 
    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Ali, H. et al. Robust antibody levels in both diabetic and non-diabetic individuals after BNT162b2 mRNA COVID-19 vaccination. Front. Immunol. 12, 752233. https://doi.org/10.3389/fimmu.2021.752233 (2021).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chandrashekar, A. et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science 369, 812–817. https://doi.org/10.1126/science.abc4776 (2020).

    ADS 
    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Deng, W. et al. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science 369, 818–823. https://doi.org/10.1126/science.abc5343 (2020).

    ADS 
    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Gao, Q. et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science 369, 77–81. https://doi.org/10.1126/science.abc1932 (2020).

    ADS 
    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Subbarao, K. SARS-CoV-2: A new song recalls an old melody. Cell Host Microbe 27, 692–694. https://doi.org/10.1016/j.chom.2020.04.019 (2020).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Abu-Farha, M. et al. Impact of diabetes in patients diagnosed with COVID-19. Front. Immunol. 11, 576818. https://doi.org/10.3389/fimmu.2020.576818 (2020).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lumeng, C. N. Innate immune activation in obesity. Mol. Aspects Med. 34, 12–29. https://doi.org/10.1016/j.mam.2012.10.002 (2013).

    ADS 
    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Pal, R. et al. Impaired anti-SARS-CoV-2 antibody response in non-severe COVID-19 patients with diabetes mellitus: A preliminary report. Diab. Metab. Syndr. 15, 193–196. https://doi.org/10.1016/j.dsx.2020.12.035 (2021).

    Article 

    Google Scholar
     

  • Perez-Galarza, J. et al. Immune response to SARS-CoV-2 infection in obesity and T2D: Literature review. Vaccines 9, 102. https://doi.org/10.3390/vaccines9020102 (2021).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260–1263. https://doi.org/10.1126/science.abb2507 (2020).

    ADS 
    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cao, W. C., Liu, W., Zhang, P. H., Zhang, F. & Richardus, J. H. Disappearance of antibodies to SARS-associated coronavirus after recovery. N. Engl. J. Med. 357, 1162–1163. https://doi.org/10.1056/NEJMc070348 (2007).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Zhang, J. S. et al. A serological survey on neutralizing antibody titer of SARS convalescent sera. J. Med. Virol. 77, 147–150. https://doi.org/10.1002/jmv.20431 (2005).

    ADS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Khoury, D. S. et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. 27, 1205–1211. https://doi.org/10.1038/s41591-021-01377-8 (2021).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Ko, J. H. et al. Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: A single centre experience. Antivir. Ther. 23, 617–622. https://doi.org/10.3851/IMP3243 (2018).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Adams, S. H., Park, M. J., Schaub, J. P., Brindis, C. D. & Irwin, C. E. Jr. Medical vulnerability of young adults to severe COVID-19 illness-data from the national health interview survey. J. Adolesc. Health 67, 362–368. https://doi.org/10.1016/j.jadohealth.2020.06.025 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Callow, K. A., Parry, H. F., Sergeant, M. & Tyrrell, D. A. The time course of the immune response to experimental coronavirus infection of man. Epidemiol. Infect. 105, 435–446. https://doi.org/10.1017/s0950268800048019 (1990).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Saxena, S. K. et al. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective. J. Med. Virol. 94, 1738–1744. https://doi.org/10.1002/jmv.27524 (2022).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Baumgarth, N., Nikolich-Zugich, J., Lee, F. E. & Bhattacharya, D. Antibody responses to SARS-CoV-2: Let’s stick to known knowns. J. Immunol. 205, 2342–2350. https://doi.org/10.4049/jimmunol.2000839 (2020).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Rydyznski Moderbacher, C. et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell 183, 996-1012 e1019. https://doi.org/10.1016/j.cell.2020.09.038 (2020).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sariol, A. & Perlman, S. Lessons for COVID-19 immunity from other coronavirus infections. Immunity 53, 248–263. https://doi.org/10.1016/j.immuni.2020.07.005 (2020).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wajnberg, A. et al. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science 370, 1227–1230. https://doi.org/10.1126/science.abd7728 (2020).

    ADS 
    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Leung, J. M. et al. ACE-2 expression in the small airway epithelia of smokers and COPD patients: Implications for COVID-19. Eur. Respir. J. 55, 2000688. https://doi.org/10.1183/13993003.00688-2020 (2020).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Liu, Y. et al. Neutralizing activity of BNT162b2-elicited serum. N Engl. J. Med. 384, 1466–1468. https://doi.org/10.1056/NEJMc2102017 (2021).

    Article 
    PubMed 

    Google Scholar
     

  • Wang, Z. et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature 592, 616–622. https://doi.org/10.1038/s41586-021-03324-6 (2021).

    ADS 
    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wu, K. et al. Serum neutralizing activity elicited by mRNA-1273 vaccine. N. Engl. J. Med. 384, 1468–1470. https://doi.org/10.1056/NEJMc2102179 (2021).

    Article 
    PubMed 

    Google Scholar
     


  • [ad_2]

    Source link

    RELATED ARTICLES

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Most Popular

    Recent Comments

    %d bloggers like this: